{"id":"W2117496910","doi":"10.1517/13543776.18.9.975","title":"Structural biology in the battle against BCR-Abl","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Vertex Pharmaceuticals; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Imatinib; Chronic myelogenous leukemia; Tyrosine kinase; Drug resistance; ABL; Tyrosine-kinase inhibitor; Drug; Cancer research; Pharmacology; Medicine; Leukemia; Biology; Cancer; Immunology; Myeloid leukemia; Internal medicine; Receptor; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001121483,0.000241815,0.0002929839,0.0001143618,0.0001355406,0.000007944217,0.0002233254,0.000136112,0.0001889689],"category_scores_gemma":[0.00004105279,0.0001442257,0.0001052594,0.0001956045,0.0001305909,0.00004879684,0.00002917618,0.0002566853,0.0002043094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000393836,"about_ca_system_score_gemma":0.0001241081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001266976,"about_ca_topic_score_gemma":0.000002348475,"domain_scores_codex":[0.9985106,0.0001769299,0.0002842306,0.0003529186,0.0002844507,0.0003908779],"domain_scores_gemma":[0.9991137,0.0001877585,0.00007272774,0.0005187786,0.00002846673,0.00007852016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002723685,0.002678586,0.475282,0.00006183094,0.001046208,0.0006958309,0.02863349,0.00009789615,0.03093969,0.002113552,0.01017359,0.4455536],"study_design_scores_gemma":[0.02385741,0.002342262,0.7893287,0.0003117691,0.0000169948,0.000742137,0.00109145,0.002141274,0.006179887,0.0004725688,0.1727409,0.000774636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877893,0.005492812,0.00001756579,0.002008975,0.001724351,0.0005714195,0.000009784949,0.00007104212,0.00231478],"genre_scores_gemma":[0.9910434,0.003170425,0.00008320613,0.005045254,0.000281603,0.00008023951,0.0001424494,0.0000280951,0.0001253512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.444779,"threshold_uncertainty_score":0.5881353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1027041500105693,"score_gpt":0.3470829673624465,"score_spread":0.2443788173518772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}